SEC Filings | Decibel Therapeutics, Inc.

Filing date	Form	Description	View
February 16, 2021	4	Statement of changes in beneficial ownership of securities	0000899243-21-006663.pdf 0000899243-21-006663.rtf 0000899243-21-006663.xls View HTML
February 16, 2021	4	Statement of changes in beneficial ownership of securities	0000899243-21-006693.pdf 0000899243-21-006693.rtf 0000899243-21-006693.xls View HTML
February 16, 2021	4	Statement of changes in beneficial ownership of securities	0000899243-21-006697.pdf 0000899243-21-006697.rtf 0000899243-21-006697.xls View HTML
February 16, 2021	4	Statement of changes in beneficial ownership of securities	0000899243-21-006704.pdf 0000899243-21-006704.rtf 0000899243-21-006704.xls View HTML
February 12, 2021	3	Initial filing by director officer or owner of more than ten percent.	0000899243-21-006212.pdf 0000899243-21-006212.rtf 0000899243-21-006212.xls View HTML
February 12, 2021	424B4	Form of prospectus disclosing information facts events covered in both forms 424B1 424B3	0001193125-21-041651.pdf 0001193125-21-041651.rtf 0001193125-21-041651.xls View HTML
February 11, 2021	3	Initial filing by director officer or owner of more than ten percent.	0001104659-21-020783.pdf 0001104659-21-020783.rtf 0001104659-21-020783.xls View HTML
February 11, 2021	3	Initial filing by director officer or owner of more than ten percent.	0001209191-21-009791.pdf 0001209191-21-009791.rtf 0001209191-21-009791.xls View HTML
February 11, 2021	3	Initial filing by director officer or owner of more than ten percent.	0001209191-21-009799.pdf 0001209191-21-009799.rtf 0001209191-21-009799.xls View HTML
February 11, 2021	3	Initial filing by director officer or owner of more than ten percent.	0001209191-21-009803.pdf 0001209191-21-009803.rtf 0001209191-21-009803.xls View HTML

Data provided by Kaleidoscope.

Main Corporate Nav